Janel Q2 2024 Earnings Report

Janel EPS Results

• Actual EPS: $0.11
• Consensus EPS: N/A
• Beat/Miss: N/A
• One Year Ago EPS: N/A

Janel Revenue Results

• Actual Revenue: $42.12 million
• Expected Revenue: N/A
• Beat/Miss: N/A
• YoY Revenue Growth: N/A

Janel Announcement Details

• Quarter: Q2 2024
• Date: 5/3/2024
• Time: N/A

Janel (OTCMKTS:JANL), through its subsidiaries, provides logistics services worldwide. It operates through three segments: Logistics, Life Sciences, and Manufacturing. The Logistics segment provides cargo transportation logistics management services, including freight forwarding by air, ocean, and land-based carriers; customs brokerage services; warehousing and distribution services; and other value added logistic services, as well as customs entry filing, cargo insurance procurement, logistics planning, product repackaging, and online shipment tracking services. The Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents, and other immuno-reagents for biomedical research; provides antibody manufacturing for academic and industry research scientists; and produces products for other life science companies on an original equipment manufacturer basis. The Manufacturing segment manufactures and distributes mixing equipment and apparatus for various industries, such as chemicals, inks, paints, construction, plastics, adhesives, cosmetics, food, and pharmaceuticals. The company was formerly known as Janel World Trade Ltd. and changed its name to Janel Corporation in April 2015. Janel Corporation was founded in 1974 and is headquartered in New York, New York.